Study assesses impact of lesion severity on coronary event risk

July 29, 2012 in Cardiology

Study assesses impact of lesion severity on coronary event risk

Contrary to previous evidence, angiographic lesion severity may predict subsequent risk of ST-segment elevation myocardial infarction within three months, according to a study published in the July 15 issue of The American Journal of Cardiology.

(HealthDay) -- Contrary to previous evidence, angiographic lesion severity may predict subsequent risk of ST-segment elevation myocardial infarction (STEMI) within three months, according to a study published in the July 15 issue of The American Journal of Cardiology.

To examine the impact of interval from initial to subsequent clinical event, Tarique Zaman, M.D., of the Jacobi Medical Center in Bronx, N.Y., and colleagues conducted a study from 2003 through 2010. Participants in the study included 84 patients with non-STEMI (NSTEMI) and 41 patients with STEMI in vessels that had been evaluated in one or more previous angiographic studies but had not received a previous intervention.

The researchers found that, with an interval of more than three months from initial angiogram to MI event, 71 percent of STEMI and 63 percent of NSTEMI patients had less than 50 percent baseline at the target site. Lesions that resulted in a STEMI within three months or less of evaluation were more severe than those leading to STEMI more than three months after evaluation, with more than 50 percent stenosis seen in 57 percent of lesions. Most baseline lesions examined three months or less before STEMI showed significant luminal narrowing, although most MIs occurred at sites that did not have significant obstruction when examined more than three months prior to MI.

"In summary, this study proposes an explanation for the uncoupling of degree of narrowing in coronary arteries and subsequent events observed previously," the authors write. "Contrary to previous studies it shows that high-grade coronary stenosis may be an important predictor of STEMI in subsequent months."

More information: Abstract
Full Text (subscription or payment may be required)

Journal reference: American Journal of Cardiology search and more info website

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 17 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 19 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 19 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 19 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created May 21, 2013 | popularity 5 / 5 (1) | comments 0


Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Rate of bicycle-related fatalities significantly lower in states with helmet laws

Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent ...

Having both migraines, depression may mean smaller brain

(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.

Novel approach for influenza vaccination shows promise in early animal testing

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...